Ellen (ELN.ST) Stock Analysis & AI Equity Report
Ellen (ELN.ST) overview
Ellen (ELN.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Ellen reported revenue of SEK 22.6m and operating profit of SEK -1.3m; the year-end share price was N/A and market capitalisation was N/A. Ellen is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Ellen's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-06-15. Data will be refreshed during report generation.
About Ellen
Ellen AB develops and markets products for women’s intimate health, including probiotic tampons, intimate care products, and related self-test and menopause items. The company’s offering is built around natural ingredients and pH-balanced intimate care, and it sells through distributors and its own channels in international markets.
Generate the Ellen report
Ellen is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Ellen and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.